Evidence map›Paper›PMID 31932468›Full record

ReviewCold Spring Harbor perspectives in medicine2020

Posttranslational Regulation and Conformational Plasticity of PTEN.

Larissa Kotelevets, Barbara Trifault, Eric Chastre, Mark G H Scott

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. The role of PTEN in puromycin aminonucleoside-induced podocyte injury.International journal of medical sciences · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Larissa KotelevetsInstitut National de la Santé et de la Recherche Médicale, Centre de Recherche Saint-Antoine, INSERM UMR S 938 Paris, Hôpital Saint-Antoine, Bâtiment Kourilsky, 75012 Paris, France.
Barbara TrifaultUniversité de Paris, 75014 Paris, France.
Eric ChastreInstitut National de la Santé et de la Recherche Médicale, Centre de Recherche Saint-Antoine, INSERM UMR S 938 Paris, Hôpital Saint-Antoine, Bâtiment Kourilsky, 75012 Paris, France.
Mark G H ScottUniversité de Paris, 75014 Paris, France.
Centre de Recherche Saint-Antoine · FRCentre National de la Recherche Scientifique · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a tumor suppressor that is frequently down-modulated in human cancer. PTEN inhibits the phosphatidylinositol 3-phosphate kinase (PI3K)/AKT pathway through its lipid phosphatase activity. Multiple PI3K/AKT-independent actions of PTEN, protein-phosphatase activities and functions within the nucleus have also been described. PTEN, therefore, regulates many cellular processes including cell proliferation, survival, genomic integrity, polarity, migration, and invasion. Even a modest decrease in the functional dose of PTEN may promote cancer development. Understanding the molecular and cellular mechanisms that regulate PTEN protein levels and function, and how these may go awry in cancer contexts, is, therefore, key to fully understanding the role of PTEN in tumorigenesis. Here, we discuss current knowledge on posttranslational control and conformational plasticity of PTEN, as well as therapeutic possibilities toward reestablishment of PTEN tumor-suppressor activity in cancer.

Indexed as

Cell ProliferationCell Transformation, NeoplasticGenes, Tumor SuppressorHumansNeoplasmsPhosphatidylinositol 3-KinasesPTEN PhosphohydrolaseSignal TransductionPhosphatidylinositol 3-KinasesPTEN PhosphohydrolasePTEN protein, human

Identifiers

PMID31932468
PMCPMC7328454
OpenAlexW2999087022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.